CRISPR/cas9 genome editing is used to replace the tryptophan at position 392 with a nonsense codon, W392X (initially published as W329X), in exon 9 . W392X is analogous to the human W402X mutation associated with severe mucopolysaccharidosis type I (MPSI). (J:300121)